Showing results (2051-2060 of 2,080) with videos related to

Sort By:
Pageof 208
Biomarker Research|October 9, 2025
Analysis of ultrastructural defects in sperm by transmission electron microscopy in asthenozoospermia patients: a study from multiple centers across ChinaMo-Qi Lv, Hai-Xu Wang, Hou-Yang Chen, et al.
Blood Advances|July 14, 2020
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCGShu-Nan Qi, Yong Yang, Yu-Qin Song, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 25, 2026
Modified gastric cancer ypTNM staging based on optimized lymph node staging: A large-sample, international multicenter studyBao-Long Li, Ru-Hong Tu, Qing Zhong, et al.
Haematologica|March 23, 2023
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG databaseXin Liu, Li-Ling Zhang, Bao-Lin Qu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2025
Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group DatabaseKe Su, Xiao-Rong Hou, Qiu-Zi Zhong, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 2, 2025
Dynamic postoperative prognosis and follow-up optimization for gastric cancer patients after neoadjuvant therapy: a multicenter retrospective studyQing Zhong, Zhi-Quan Zhang, Kai-Ning Ye, et al.
Therapeutic Advances in Medical Oncology|October 14, 2024
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphomaFei Luo, Qiu-Zi Zhong, Xin Liu, et al.
Blood Advances|April 20, 2023
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm studyLi-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, et al.
Chinese Journal of Cancer|September 9, 2017
Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002-2011)Lan-Wei Guo, Hui-Yao Huang, Ju-Fang Shi, et al.
Breast (Edinburgh, Scotland)|March 30, 2018
Health-related quality of life and utility scores of patients with breast neoplasms in China: A multicenter cross-sectional surveyLe Wang, Ju-Fang Shi, Juan Zhu, et al.
Pageof 208